Cancer Liaison Program
Cancer Related Articles
2004
- New Treatments for Colorectal
Cancer, FDA Consumer, May-June
- Cervical Cancer Screening,
Linda Bren, FDA Consumer, January-February
2003
- Statement of Theresa M. Mullin, Ph.D.,
Assistant Commissioner for Planning, FDA, Before the Subcommittee on Health
Committee on Energy and Commerce, House of Representatives Hearing about collaborative
efforts with the National Cancer Institute to facilitate cancer drug development,
July 10
- Speedy Approvals for New Cancer
Treatments, FDA Consumer, July-August
- Joint FDA, NCI Program Aims
to Streamline Cancer Drug Development, FDA Consumer, July-August
- Turning Up the Heat on Acrylamide,
Linda Bren, FDA Consumer, January-February
2002
- FDA Public Meeting on Acrylamide
in the U.S. Food Supply, Remarks by Lester M. Crawford, Jr., D.V.M., Ph.D.,
FDA Deputy Commissioner, September 30
- The FDA's Drug Review Process:
Ensuring Drugs are Safe and Effective, FDA Consumer, July-August
- Bringing Real Life to the Table:
Patient Reps Help FDA Review Products, FDA Consumer, January-February
2002
- FDA Approves Gleevec for Leukemia
Treatment, FDA Consumer, July-August
- Grappling With the Quality of
Life: Patients, FDA and Drug Companies Struggle to Link Therapies With Well-Being,
Carol Lewis, FDA Consumer, March-April
- Testimony of Robert J. Temple,
M.D., Associate Director for Medical Policy, Center for Drug
Evaluation and Research and Patty Delaney, Cancer Liaison Program, Office
of Special Health Issues, to discuss an important issue of the availability
of investigational drugs for what is commonly referred to as compassionate
use before the Committee on Government Reform, U.S. House of Representatives,
June 20
2000
1999
- Breast Cancer: Better Treatments
Save More Lives, Carol Lewis, FDA Consumer, July-August
- FDA Response to letters requesting approval of
temozolomide for the treatment of adult patients with malignant glioma at
first relapse, April 14
- Waging a War on Lung Cancer,
Ellen Brown, FDA Consumer, May-June
- Safer Sunning in Seven Steps
(FDA 99-1279)
[also available as a 1.38MB PDF file]
1998
1997
- Understanding Clinical Trials From the Patient's Perspective,
by Patty Delaney, May/June
- The FDA, What Does It Do For Cancer Patients?,
by Patty Delaney, September/October
- Cancer Clinical Trials Listing, an alphabetical
listing of cancer organizations wiht extensive information about cancer treatments
and clinical trials.
- Waging War on Lung Cancer,
by Ellen Brown, FDA Consumer May-June
- Prostate Cancer, No One
Answer for Testing or Treatment, by John Henkel, FDA Consumer, September/October
- Prostate Cancer, New Tests Create
Treatment Dilemmas by John Henkel, FDA Consumer, July
- The Value of Patient's Perspective in FDA Decision
Processes, Sharon Smith Holston, Deputy Commissioner for External Affairs,
November 3, 1997
- Giving Thalidomide a Second
Chance, by Herbert Burkholz, FDA Consumer, September-October
- Thalidomide, Important Patient Information
Center for Drug Evaluation and Research, FDA
- Thalidomide: Potential Benefits and Risks,
Executive Summary of an Open Public Scientific Workshop, National Institutes
of Health, September 9-10
1996
1995